Here at Uson, we are obsessed with leak testing methods. One problem that we see often, particularly in the medical device industry, is the widespread belief that one type of leak test method is inherently better for nearly all applications. This is simply not true and the misinformation seems to have taken on a life of its own.
A new formulation of synthetic, biochemically absorbable polymers is creating opportunities in the medical device and pharmaceutical fields. These “bioabsorbable polymers” are materials designed to dissolve into compounds that the body can safely absorb or eliminate.
Researchers in the University’s Physics and Pharmacy & Pharmacology Departments are using a pioneering technique to study the properties and characteristics of our skin, in tests that could pave the way for new treatments for dermatitis, and for an improved understanding of the skin ageing process.
In the near future, a buzz in your belt or a pulse from your jacket may give you instructions on how to navigate your surroundings. Think of it as tactile Morse code: vibrations from a wearable, GPS-linked device that tell you to turn right or left, or stop, depending on the pattern of pulses you feel. Such a device could free drivers from having to look at maps, and could also serve as a tactile guide for the visually and hearing impaired.
Out in the wilds or anywhere off the grid, sophisticated instruments small enough to fit in a shirt pocket will one day scavenge power from sunlight, body heat, or other sources to monitor water quality or bridge safety or function as wearable biomedical monitors, enabling analysis in the field rather than bringing samples and data back to the lab.
A medical test previously developed to measure a toxin found in tobacco smokers has been adapted to measure the same toxin in people suffering from spinal cord injuries and multiple sclerosis, offering a potential tool to reduce symptoms.
Texas Instruments Incorporated (TI) introduced two tiny push-button reset controllers for space-constrained, power-sensitive applications such as pedometers, fitness bands, cell phones and tablets. The dual-channel TPS3420 and TPS3421 feature low power consumption and a selectable reset time delay to improve system stability.
The new Flare, a compact, pulsed laser from Coherent provides a superior and cost-effective alternative to older gas lasers and first-generation solid-state lasers for life sciences and instrumentation applications. The Flare series has three wavelength versions available - near infrared (1064 nm), green (532 nm) and ultraviolet (355 nm).
TandD Corp. has introduced the NEW RTR-505P Wireless Pulse Counting Data Logger. This NEW model can record pulses from devices such as flow meters, anemometers or the opening and closing of switches from a variety of sensors. By using any of the RTR-500 Series Base Units, the recorded data can be collected via wireless communication.
Lumex has announced the global launch of its TitanBrite Wireless Bonded LED featuring “flip chips” that are up to 15% brighter than any others in the market. In addition to the standard 3W and 6W LEDs, Lumex’s TitanBrite Wireless Bonded LED is also available in 9W, ensuring Lumex’s wireless bonded LED is the brightest light source in the industry.
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke, the company announced today at the Live Interventional Neuroradiology & Neurosurgery Course (LINNC) in Paris.
A 10-year-old girl with cystic fibrosis was recovering from a transplant of adult lungs after a judge's ruling expanded her options for lifesaving surgery. Sarah Murnaghan underwent a six-hour surgery Wednesday at the Children's Hospital of Philadelphia, a procedure her aunt said resulted because of the larger list of available organs.
The Supreme Court ruled Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries. The high court's unanimous judgment reverses three decades of patent awards by government officials.
According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer. In addition to detecting a unique odor signature associated with melanoma cells, the researchers also demonstrated that a nanotechnology-based sensor could reliably differentiate melanoma cells from normal skin cells.
Medical device professionals will learn what they need to know about manufacturing combinations products and FDA Regulations at a workshop to be featured at MD&M East, the world's largest medical OEM event, in Philadelphia on Tuesday, June 18, 2013.